Searching map area
Michele Baccarani
? TBD
researcher
Join to rate
Ratings
0
Nobody has rated this yet. Be the first!
Works
13
Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia
article by Simona Soverini et al published 15 December 2006 in Clinical Cancer Research
Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party
article by Gabriele Gugliotta et al published 26 May 2011 in Blood
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients
scientific article
Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis
scientific article
Phase II trial of temozolomide in patients with pretreated cutaneous T-cell lymphoma.
scientific article
B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
scientific article
First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma.
scientific article published in July 2004
Nilotinib against high dose imatinib for salvage therapy of chronic myeloid leukaemia
article
Update on the treatment of disseminated fusariosis: Focus on voriconazole.
scientific article published on December 2007
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party o
article by Simona Soverini et al published 20 June 2005 in Journal of Clinical Oncology
3 more
Lists
0
Join to rate
Instance of
Human
Occupation
Researcher
Wikidata